HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy
Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy
Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy
Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases
Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations
Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States
Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women
Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain
Transient or occult HIV-1 infection in high-risk adults
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Accumulation of lopinavir resistance-associated mutations over 3 years follow-up of patients on highly active antiretroviral therapy: implication in salvage therapy
Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy
Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children
Circumcision and male-to-male sexual transmission of HIV
Secondary structure predictions of HIV-1 reverse transcriptase provide new insights into the development of drug-resistance genotypes
Efavirenz plasma concentrations and efficiency
`Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients'
l-Carnitine for the treatment of highly active antiretroviral therapy-related hypertriglyceridemia in HIV-infected adults
Mother to Child Transmission: European Collaborative Study
BK virus encephalitis in a patient with AIDS and lymphoma